JPM
JPMorgan Chase & Co.
JPM has a slight edge over QCRH overall, supported by stronger modeled upside and lower modeled downside.
QCRH
QCR Holdings, Inc.
QCRH offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
QCRH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
QCRH's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like QCRH.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over QCRH in the historical PE scenario, which offers more potential upside but is not a forecast.
QCRH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.2x | $69.92 | -32% |
| Fair | 10x | $85.51 | -17% |
| Expensive | 12x | $99.81 | -3.4% |
| Current | 12x | $103 | — |
| Forward | 12x | $103 | — |
Historical ranges are pointers, not guarantees.
QCRH's PE is in its expensive range at 12.2x. If earnings grow as analysts expect, today's price would be 11.6x next year's earnings.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
QCRH Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
QCRH has the edge over JPM on the outlook, with more favorable valuation expectations.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over QCRH on earnings, with more consistent year-over-year improvement.
QCRH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $8.94 | +5.3% |
| Q3 2026 | $8.49 | +19% |
| Q2 2026 | $8.44 | +27% |
| Q1 2026 | $7.96 | +20% |
| Q4 2025 | $7.49 | +12% |
| Q3 2025 | $7.16 | +3.9% |
| Q2 2025 | $6.64 | -1.5% |
| Q1 2025 | $6.65 | -0.9% |
| Q4 2024 | $6.71 | -0.3% |
QCRH earned $8.49 per share over the past year, up 19% from the year before.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM has the edge over QCRH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM's operating margin was 40% last quarter, about level with the same quarter a year ago.
QCRH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $99.2M | -2.2% |
| Q2 2026 | $97.3M | +16% |
| Q1 2026 | $90.4M | +18% |
| Q4 2025 | $107M | +17% |
| Q3 2025 | $101.5M | +17% |
| Q2 2025 | $84.2M | -3.3% |
| Q1 2025 | $76.9M | -5.7% |
| Q4 2024 | $91.8M | -11% |
QCRH's revenue has picked up after two years of holding roughly level: $99M last quarter, down 2.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | +0.4 points |
| Q2 2026 | 41% | +4.3 points |
| Q1 2026 | 40% | +5.7 points |
| Q4 2025 | 36% | 0 points |
| Q3 2025 | 40% | +5.6 points |
| Q2 2025 | 36% | -0.1 points |
| Q1 2025 | 34% | -0.3 points |
| Q4 2024 | 36% | +0.1 points |
QCRH has the edge over JPM on profitability, with a higher operating margin.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
QCRH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $11.9M | -63% |
| Q2 2026 | $458.1M | +1792% |
| Q1 2026 | -$7.9M | +$4.8M |
| Q4 2025 | $310.8M | +90% |
| Q3 2025 | $31.7M | -86% |
| Q2 2025 | $24.2M | +50% |
| Q1 2025 | -$12.7M | -$3.3M |
| Q4 2024 | $163.4M | -42% |
QCRH has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has 2.7B diluted shares, down 3.1% from a year ago, with $24.5B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
QCRH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.7% | -119K shares |
| 1 year | -3.3% | -565K shares |
| 3 years | -2.4% | -397K shares |
| 5 years | +3.7% | +581K shares |
| Available history | +3% | +483K shares |
QCRH has the edge over JPM on shareholder dilution, with a more favorable share count trend.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM has the edge over QCRH on leverage, with a lower net debt burden relative to earnings.
QCRH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.5x | Healthy |
| Q2 2026 | 1.4x | Healthy |
| Q1 2026 | 1.7x | Healthy |
| Q4 2025 | 1.8x | Healthy |
| Q3 2025 | 2.0x | Moderate |
| Q2 2025 | 1.0x | Healthy |
| Q1 2025 | 1.0x | Healthy |
| Q4 2024 | 1.1x | Healthy |
QCRH's net debt is about 1.5 years of its operating earnings (EBITDA), down from 2.0 years a year ago. Net leverage isn't a meaningful measure for financial services companies like QCRH.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
QCRH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.2 | Neutral |
| Stochastic | 49.4 | Neutral |
QCRH's weekly RSI is 59 (neutral) and its Stochastic is 49 (neutral).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
QCRH PE vs Financial Services Sector
| Metric | QCRH | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 6.5% below |
| PE % | 91 | 63 | 28 pts above |
QCRH has the edge over JPM on valuation relative to its sector.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
QCRH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $100.9 | 2.5% above |
| 20 week MA | $101.0 | 2.4% above |
| 50 week MA | $93.7 | 10% above |
| 100 week MA | $83.6 | 24% above |
| 200 week MA | $70.6 | 46% above |
QCRH has the edge over JPM on trend strength, trading above more of its moving averages.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.
QCRH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $43.3 | $39.7 | -8.4% |
| 2021 | $39.7 | $55.3 | +39% |
| 2022 | $55.3 | $50.0 | -9.7% |
| 2023 | $50.0 | $58.4 | +17% |
| 2024 | $58.4 | $80.8 | +38% |
| 2025 | $80.8 | $84.8 | +4.9% |
| 2026 YTD | $84.8 | $103.4 | +22% |
QCRH has the edge over JPM on returns for 2026, with the stronger performance.